euro adhoc: Sartorius AG
Mergers - Acquisitions - Takeovers
End of Sartorius
AG´s tender offer to minority shareholders of
Sartorius Stedim Biotech S.A.
As expected, no shares were sold to Sartorius AG
Thus, Sartorius AG holds
69.8% of the share
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
27.07.2007
Today, upon the announcement of the French exchange supervisory authority AMF on the acceptance quota, Sartorius AG´s tender offer has officially ended after the acceptance period had already expired yesterday, July 26, 2007. As expected, no shares were sold to Sartorius AG so that the shareholder structure of Sartorius Stedim Biotech S.A. at the end of the tender offer is as follows: Sartorius AG directly and indirectly holds a total of 69.8% of the shares and is thus majority shareholder with a controlling stake. Additional shareholders are the Stedim founders, who hold 9.0% of the shares. Shares in free float are 21.3%.
end of announcement euro adhoc 27.07.2007 14:42:19
Further inquiry note:
Andreas Wiederhold
Telefon: +49 (0)551 308-1668
E-Mail: andreas.wiederhold@sartorius.com
Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / official dealing/prime standard
Börse Berlin / free trade
Börse Hamburg / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse München / free trade
Börse Hannover / official dealing